BSECompany Update9 Oct 2026 · 9 Oct 2026, 11:40 am

Intimation about change in name of Director from Dr Neeti Madan Kapre to Dr Neeti Gupta

Sandu Pharmaceuticals Ltd · 524703

✦ AI SummaryMgmt Change

Sandu Pharmaceuticals Ltd has informed the exchange about a change in the name of its non-executive independent director, Dr. Neeti Madan Kapre, to Dr. Neeti Gupta, due to her marriage, with no change in designation, directorship, or DIN.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Sandu Pharmaceuticals Ltd - 524703 - Intimation Regarding Change In Name Of Director From Dr Neeti Madan Kapre To Dr Neeti Gupta.

Attachments (1)

📄

b362342e-920b-4715-b4ba-5a7ac86cd540.pdf

pdf

Download →
View document text
-::' SANDU PHARMACEUTICALS LIMITED SANDU CIN:L24233GA1985PLC001587 W Regd. Office: Plot Nos. 25, 26, 29 & 30, Pilerne Industrial Estate, Marra, Saligao, Bardez, Goa 403511. Tel: +91 832 2407474 / 6715000, E-mail: sandupharma@sandu.in, Website: www.sandu.in Ref: Corp.Sec/2026-27/BSE/498 Dated:09.10.2026 BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai-400001 SCRIPTCODE:524703 Dear Sir/Ma’am, Sub: Intimation regarding change in name of Director from Dr Neeti Madan Kapre to Dr Neeti Gupta. Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the name of Dr Neeti Madan Kapre (DIN: 06801264, [Non Executive Independent Director] of the Company, has been changed from Dr Neeti Madan Kapre to Dr Neeti Gupta consequent upon her marriage. The change in name has been duly supported by the relevant documentary evidence and the same has been taken on record by the Company. We further confirm that there is no change in the designation, directorship or DIN of the Director, and the aforesaid intimation is only in respect of the change in her name. This is for your information and appropriate dissemination. Thanking you, Yours faithfully, For. Sandu Pharmaceuticals Limited Pratika Mhambray Company Secretary and Compliance Officer A36512 AN 1SO 9001:2015 CERTIFIED ORGANISATION Corporate Office: P. B. No. 17201, Sandu Nagar, D. K. Sandu Marg, Chembur, Mumbai — 400 071 Tel.: +91 22 2528 4402 / 3306, E-mail: info@sandu.in %u % __ SANDU PHARMACEUTICALS LIMITED (CIN:L24233GA1985PLC001587 SAMDU m Regd. Office: Plot Nos. 25, 26, 29 & 30, Pilerne Industrial Estate, Marra, Saligao, Bardez, Goa 403511. Tel: +91 832 2407474 / 6715000, E-mail: sandupharma@sandu.in, Website: www.sandu.in ANNEXURE A Disclosures as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Sr Particulars Details 1 Name of the Director/ Key | Dr Neeti Gupta (DIN:06801264) Managerial Personnel 2 Reason for change Change of Name from Dr Neeti Madan Kapre (DIN:06801264) to Dr Neeti Gupta 3 Date of appointment | NA /Cessation & term of appointment 4 Brief Profile NA 5 Disclosure of | NA relationships between directors (in case of appointment of a director) 6 Information as required | NA Circular No. LIST/COMP/ 14/2018- 19 and NSE/CML/2018/24 For. Sandu Pharmaceuticals Limited Pratika Mhambray Company Secretary and Compliance Officer A 36512 AN 1SO 9001:2015 CERTIFIED ORGANISATION Corporate Office: P. B. No. 17201, Sandu Nagar, D. K. Sandu Marg, Chembur, Mumbai — 400 071 Tel.: +91 22 2528 4402 / 3306, E-mail: info@sandu.in